Recent Progress Towards a Gonococcal Vaccine

Gonorrhea is a global health concern. Its etiological agent, Neisseria gonorrhoeae, rapidly acquires antimicrobial resistance and does not confer protective immunity as a consequence of infection. Attempts to generate an effective vaccine for gonorrhea have thus far been unsuccessful, as many struct...

Full description

Bibliographic Details
Main Authors: Stavros A. Maurakis, Cynthia Nau Cornelissen
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-04-01
Series:Frontiers in Cellular and Infection Microbiology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcimb.2022.881392/full
_version_ 1819023905785905152
author Stavros A. Maurakis
Cynthia Nau Cornelissen
author_facet Stavros A. Maurakis
Cynthia Nau Cornelissen
author_sort Stavros A. Maurakis
collection DOAJ
description Gonorrhea is a global health concern. Its etiological agent, Neisseria gonorrhoeae, rapidly acquires antimicrobial resistance and does not confer protective immunity as a consequence of infection. Attempts to generate an effective vaccine for gonorrhea have thus far been unsuccessful, as many structures on the bacterial envelope have the propensity to rapidly change, thus complicating recognition by the human immune system. In response to recent efforts from global health authorities to spur the efforts towards development of a vaccine, several new and promising steps have been made towards this goal, aided by advancements in computational epitope identification and prediction methods. Here, we provide a short review of recent progress towards a viable gonococcal vaccine, with a focus on antigen identification and characterization, and discuss a few of the tools that may be important in furthering these efforts.
first_indexed 2024-12-21T04:46:19Z
format Article
id doaj.art-e11dd6d75eb742fb98baee9d79899727
institution Directory Open Access Journal
issn 2235-2988
language English
last_indexed 2024-12-21T04:46:19Z
publishDate 2022-04-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cellular and Infection Microbiology
spelling doaj.art-e11dd6d75eb742fb98baee9d798997272022-12-21T19:15:35ZengFrontiers Media S.A.Frontiers in Cellular and Infection Microbiology2235-29882022-04-011210.3389/fcimb.2022.881392881392Recent Progress Towards a Gonococcal VaccineStavros A. MaurakisCynthia Nau CornelissenGonorrhea is a global health concern. Its etiological agent, Neisseria gonorrhoeae, rapidly acquires antimicrobial resistance and does not confer protective immunity as a consequence of infection. Attempts to generate an effective vaccine for gonorrhea have thus far been unsuccessful, as many structures on the bacterial envelope have the propensity to rapidly change, thus complicating recognition by the human immune system. In response to recent efforts from global health authorities to spur the efforts towards development of a vaccine, several new and promising steps have been made towards this goal, aided by advancements in computational epitope identification and prediction methods. Here, we provide a short review of recent progress towards a viable gonococcal vaccine, with a focus on antigen identification and characterization, and discuss a few of the tools that may be important in furthering these efforts.https://www.frontiersin.org/articles/10.3389/fcimb.2022.881392/fullNeisseria gonorrhoeaegonorrheavaccinesexually-transmitted infectionsimmunityepitope
spellingShingle Stavros A. Maurakis
Cynthia Nau Cornelissen
Recent Progress Towards a Gonococcal Vaccine
Frontiers in Cellular and Infection Microbiology
Neisseria gonorrhoeae
gonorrhea
vaccine
sexually-transmitted infections
immunity
epitope
title Recent Progress Towards a Gonococcal Vaccine
title_full Recent Progress Towards a Gonococcal Vaccine
title_fullStr Recent Progress Towards a Gonococcal Vaccine
title_full_unstemmed Recent Progress Towards a Gonococcal Vaccine
title_short Recent Progress Towards a Gonococcal Vaccine
title_sort recent progress towards a gonococcal vaccine
topic Neisseria gonorrhoeae
gonorrhea
vaccine
sexually-transmitted infections
immunity
epitope
url https://www.frontiersin.org/articles/10.3389/fcimb.2022.881392/full
work_keys_str_mv AT stavrosamaurakis recentprogresstowardsagonococcalvaccine
AT cynthianaucornelissen recentprogresstowardsagonococcalvaccine